This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Randolph, J. F. Articles by Little, R. J. Search for Related Content PubMed PubMed Citation Articles by Randolph, J. F., Jr. Articles by Little, R. J.

Change in Estradiol and Follicle-Stimulating Hormone across the Early Menopausal Transition: Effects of Ethnicity and Age

Department of Obstetrics and Gynecology, School of Medicine (J.F.R.), and Departments of Epidemiology (MF.S., I.V.B., S.D.H.) and Biostatistics (R.J.L.), School of Public Health, University of Michigan, Ann Arbor, Michigan 48109; and Department of Obstetrics and Gynecology (J.L.L.), Rush University Medical Center, Chicago, Illinois 60612

Address all correspondence and requests for reprints to: John F. Randolph, Jr., M.D., L4228 Women’s Hospital, University of Michigan Health System, 1500 East Medical Center Drive, Ann Arbor, Michigan 48109-0276. E-mail: jfrandol{at}med.umich.edu.

Serum reproductive hormone concentrations were measured longitudinally in a community-based, multiethnic population of midlife women to assess whether ethnic differences exist in the patterns of change in estradiol (E2) and FSH and, if so, whether these differences are explained by host characteristics. We studied 3257 participants from seven clinical sites in the Study of Women’s Health Across the Nation (SWAN) who were aged 42–52 yr at baseline and self-identified as African American (28.2%), Caucasian (47.1%), Chinese (7.7%), Hispanic (8.4%), or Japanese (8.6%). E2 and FSH were assayed in serum collected primarily in the early follicular phase of a spontaneous menstrual cycle in three consecutive annual visits. The primary explanatory variables included in repeated-measures regression analyses were race/ethnicity, menopausal status, age, body mass index (BMI), day of the cycle, smoking, parity, socioeconomic status, study site, and the self-report of diabetes at baseline.

At the baseline visit, 46.2% of the women were classified as being early perimenopausal, with the remaining being premenopausal. By the second follow-up visit, 5.5% of the women in that cohort were postmenopausal, 66.8% were early perimenopausal, 8.3% were late perimenopausal, and 19.4% remained premenopausal.

Serum E2 concentrations decreased significantly with age, with a steeper decline at higher ages. FSH concentrations increased significantly with age, with a steeper increase at higher ages. Similar patterns in the decline of E2 and the increase in FSH with age were found across ethnic groups, but the levels of these hormones differed by race/ethnicity. Specifically, over time, Chinese and Japanese women had lower E2 concentrations but similar FSH levels, compared with Caucasian women, and African American women had higher FSH concentrations but comparable E2 levels with those of Caucasian women. These ethnic differences in E2 and FSH were independent of menopausal status. The effect of BMI on serum E2 and FSH levels varied by menopausal status. Increasing BMI was associated with decreasing concentrations of E2 among premenopausal and early perimenopausal women but was associated with increasing concentrations of E2 among late perimenopausal and postmenopausal women. Increasing BMI was associated with decreasing concentrations of FSH, with the effect of BMI becoming larger as women transitioned through menopause.

We conclude that serum E2 levels decrease and FSH concentrations increase with increasing age in midlife women, that ethnic differences in E2 over time differ from ethnic differences in FSH and suggest ethnic differences in the pituitary-ovarian relationship, and that the effect of BMI on E2 and FSH concentrations varies by menopausal status.

The Study of Women’s Health Across the Nation (SWAN) was funded by the National Institute on Aging, National Institute of Nursing Research, and Office of Research on Women’s Health of the National Institutes of Health. Supplemental funding from the National Institute of Mental Health, National Institute on Child Health and Human Development, National Center on Complementary and Alternative Medicine, Office of Minority Health, and Office of AIDS Research is also gratefully acknowledged.

Clinical Centers: University of Michigan, Ann Arbor, Michigan (U01 NR04061, MaryFran Sowers, PI); Massachusetts General Hospital, Boston, Massachusetts (U01 AG12531, Joel Finkelstein, PI); Rush University, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, Illinois (U01 AG12505, Lynda Powell, PI); University of California, Davis/Kaiser, California (U01 AG12554, Ellen Gold, PI); University of California, Los Angeles, California (U01 AG12539, Gail Greendale, PI); University of Medicine and Dentistry/New Jersey Medical School, Newark, New Jersey (U01 AG12535, Gerson Weiss, PI); and the University of Pittsburgh, Pittsburgh, Pennsylvania (U01 AG12546, Karen Matthews, PI).

Laboratory: University of Michigan, Ann Arbor, Michigan (U01 AG12495, Central Ligand Assay Satellite Services, Daniel McConnell, PI) and Medical Research Laboratories, Highland Heights, Kentucky (subcontract of U01 AG12553, Evan Stein, Director).

Coordinating Center: University of Pittsburgh, Pittsburgh, Pennsylvania (Kim Sutton-Tyrrell, PI).

Project Officers: Janice Phillips, Sherry Sherman.

Steering Committee Chair: Susan Johnson.

Abbreviations: BMI, Body mass index; E2, estradiol; SWAN, Study of Women’s Health Across the Nation.

This article has been cited by other articles:

				R. C. Thurston, M. R. Sowers, B. Sternfeld, E. B. Gold, J. Bromberger, Y. Chang, H. Joffe, C. J. Crandall, L. E. Waetjen, and K. A. Matthews Gains in Body Fat and Vasomotor Symptom Reporting Over the Menopausal Transition: The Study of Women's Health Across the Nation Am. J. Epidemiol., September 15, 2009; 170(6): 766 - 774. [Abstract] [Full Text] [PDF]

				C. A. Derby, S. L. Crawford, R. C. Pasternak, M. Sowers, B. Sternfeld, and K. A. Matthews Lipid Changes During the Menopause Transition in Relation to Age and Weight: The Study of Women's Health Across the Nation Am. J. Epidemiol., June 1, 2009; 169(11): 1352 - 1361. [Abstract] [Full Text] [PDF]

				K. A. O'Connor, R. J. Ferrell, E. Brindle, J. Shofer, D. J. Holman, R. C. Miller, D. E. Schechter, B. Singer, and M. Weinstein Total and Unopposed Estrogen Exposure across Stages of the Transition to Menopause Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 828 - 836. [Abstract] [Full Text] [PDF]

				M. R. Sowers, H. Zheng, D. McConnell, B. Nan, S. D. Harlow, and J. F. Randolph Jr. Estradiol Rates of Change in Relation to the Final Menstrual Period in a Population-Based Cohort of Women J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3847 - 3852. [Abstract] [Full Text] [PDF]

				N. Santoro, S. L. Crawford, W. L. Lasley, J. L. Luborsky, K. A. Matthews, D. McConnell, J. F. Randolph Jr., E. B. Gold, G. A. Greendale, S. G. Korenman, et al. Factors Related to Declining Luteal Function in Women during the Menopausal Transition J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1711 - 1721. [Abstract] [Full Text] [PDF]

				G. E. Hale, X. Zhao, C. L. Hughes, H. G. Burger, D. M. Robertson, and I. S. Fraser Endocrine Features of Menstrual Cycles in Middle and Late Reproductive Age and the Menopausal Transition Classified According to the Staging of Reproductive Aging Workshop (STRAW) Staging System J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3060 - 3067. [Abstract] [Full Text] [PDF]

				M. H. Tao, Q. Cai, W. H. Xu, N. Kataoka, W. Wen, W. Zheng, Y. B. Xiang, Z.-F. Zhang, and X. O. Shu Cytochrome P450 1B1 and Catechol-O-Methyltransferase Genetic Polymorphisms and Endometrial Cancer Risk in Chinese Women Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2570 - 2573. [Full Text] [PDF]

				D. Grady Management of Menopausal Symptoms N. Engl. J. Med., November 30, 2006; 355(22): 2338 - 2347. [Full Text] [PDF]

				B Moy, D Tu, J. Pater, J. Ingle, L. Shepherd, T. Whelan, and P. Goss Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer Ann. Onc., November 1, 2006; 17(11): 1637 - 1643. [Abstract] [Full Text] [PDF]

				J. F. Randolph Jr., S. Crawford, L. Dennerstein, K. Cain, S. D. Harlow, R. Little, E. S. Mitchell, B. Nan, J. Taffe, and M. Yosef The Value of Follicle-Stimulating Hormone Concentration and Clinical Findings as Markers of the Late Menopausal Transition J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3034 - 3040. [Abstract] [Full Text] [PDF]

				P. Y. Liu, K. A. Hoey, K. L. Mielke, J. D. Veldhuis, and S. Khosla A Randomized Placebo-Controlled Trial of Short-Term Graded Transdermal Estradiol in Healthy Gonadotropin-Releasing Hormone Agonist-Suppressed Pre- and Postmenopausal Women: Effects on Serum Markers of Bone Turnover, Insulin-Like Growth Factor-I, and Osteoclastogenic Mediators J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 1953 - 1960. [Abstract] [Full Text] [PDF]

				L. A. Newman Breast Cancer in African-American Women Oncologist, January 1, 2005; 10(1): 1 - 14. [Abstract] [Full Text] [PDF]